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 ARMS Subjects 
(SD) 
Healthy Controls 
(SD) 
Difference  
(p value) 
Count 69 32  
Age 21.52 (3.49) 22.97 (3.94) 0.07 
Gender   0.15 
Male % 68 53  
Female % 32 47  
Handedness   0.64 
Right-handed % 84 91  
Left-handed % 7 3  
Ambidextrous % 9 6  
Ethnicity   0.13 
Chinese % 67 56  
Malay % 23 16  
Indian % 6 19  
Other % 4 9  
Education    
PSLE  196.3 (47.75) 206.1 (31.34) 0.48 
Baseline clinical scores    
CAARMS positive 16.33 (7.35) -  
GRD % 30 -  
APS % 81 -  
BLIPS % 7 -  
CDSS 5.42 (4.61) -  
BAI 20.74 (11.16) -  
Comorbidities    
Depression and/or anxiety % 48 0  
Past history SUD    
Alcohol % 6 3 0.56 
Illicit drug % 3 0 0.33 
Brain volumes    
VBM - ICV (ml) 1502.18 (141.05) 1448.24 (118.67) 0.59 
SBM - ICV (ml) 1465.61 (146.64) 1410.48 (152.81) 0.31 
SBM - Total GM (ml) 685.71 (55.49) 663.55 (47.09) 0.79 
SBM - Total WM (ml) 470.84 (52.12) 460.79 (47.80) 0.38 
Hippocampi (ml) 8.73 (0.76) 8.72 (0.61) 0.09 
Ventricles (ml) 14.91 (6.88) 12.60 (5.54) 0.22 
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Abstract 40 
There is cumulative evidence that young people in an “at risk mental state” (ARMS) for 41 
psychosis show structural brain abnormalities in fronto-limbic areas, comparable to, but less 42 
extensive than those reported in established schizophrenia. However, most available data come 43 
from ARMS samples from Australia, Europe and North America while large studies from other 44 
populations are missing. We conducted a structural brain magnetic resonance imaging (MRI) study 45 
from a relatively large sample of 69 ARMS individuals and 32 matched healthy controls recruited 46 
from Singapore as part of the Longitudinal Youth At-Risk Study (LYRIKS). We used two 47 
complementary approaches: a voxel-based morphometry (VBM) and a surface-based morphometry 48 
(SBM) analysis to extract regional gray and white matter volumes (GMV and WMV) and cortical 49 
thickness (CT). At the whole brain-level, we did not find any statistically significant difference 50 
between ARMS and healthy controls (HC) groups concerning total GMV and WMV or regional 51 
GMV, WMV and CT. The additional comparison of two regions of interest, hippocampal and 52 
ventricular volumes, did not return any significant difference either. Several characteristics of the 53 
LYRIKS sample like Asian origins or the absence of current illicit drug use could explain, alone or 54 
in conjunction the negative findings and suggest that there may be no dramatic volumetric or 55 
cortical thickness abnormalities in ARMS. 56 
 57 
Keywords 58 
magnetic resonance imaging  59 
voxel-based morphometry 60 
surface-based morphometry 61 
early psychosis 62 
schizophrenia 63 
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Introduction 64 
Adolescents and young adults in the putative prodrome of psychotic illness – variously 65 
labeled as being at "ultra high risk" (UHR), "clinical high risk" (CHR), or in an "at risk mental 66 
state" (ARMS) – experience distressing sub-threshold psychotic symptoms and have a 30-43% risk 67 
of transition to psychosis over a 36 month-period 1. These individuals are typically identified 68 
through clinical assessment of help-seeking individuals who present (i) attenuated or (ii) brief and 69 
intermittent psychotic symptoms, or (iii) a decrease in global functioning combined with a genetic 70 
risk for psychosis 2,3. 71 
Structural MRI brain studies have featured prominently in attempts to identify biomarkers of 72 
ARMS. In general, this work has shown baseline grey matter volume (GMV) reductions in frontal, 73 
temporal and limbic areas of ARMS individuals 4-10. Though the results of ARMS MRI research, 74 
typically obtained in small samples, are heterogeneous and contradictory 11,12, many of the 75 
identified brain changes are similar to those seen in patients with established schizophrenia 13,14. 76 
Some GMV reductions, particularly in fronto-limbic areas, have been confirmed to be statistically 77 
robust through meta-analysis 15 and multi-centre investigations 16. 78 
In parallel to GMV findings, only four whole-brain studies compared cortical thickness 79 
between ARMS individuals and controls and their results were divergent. One study reported 80 
cortical thinning in several brain regions, including frontal, temporal and limbic areas 17 while three 81 
studies did not report any cortical thinning significant at the whole-brain level in a larger sample of 82 
ARMS individuals when compared at baseline with healthy controls (HC) 18-20.  83 
Fewer studies have investigated alterations of white matter volume (WMV) in ARMS but 84 
their findings are consistent with what has been reported for GMV. They reported smaller WMV in 85 
fronto-temporo-limbic areas 5,6,21 as well as a global reduction of WM growth over time 22 in ARMS 86 
compared to HC.  87 
While baseline comparisons between ARMS and HC are useful for identifying putative 88 
biomarkers of young people in need of care, the majority of ARMS individuals do not transition to 89 
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frank psychosis (ARMS-NT), spurring attempts to identify ARMS individuals at incipient risk of 90 
psychosis onset (ARMS-T). At the whole-brain level, gray matter differences associated with 91 
transition to psychosis have been localized in the same fronto-temporo-limbic regions that also 92 
distinguish the overall ARMS group (regardless of transition) from HC 4,6,23,24. More precisely, 93 
baseline GMV reductions in ARMS-T when compared to ARMS-NT were especially consistent in 94 
the fronto-insular and superior temporal regions 15.   95 
All these studies recruited ARMS samples from North America, Europe and Australia. There 96 
are few structural brain MRI studies performed in ARMS samples from Asia and all were 97 
conducted in small cohorts 17,25,26. Nevertheless, establishing consistency across different ethnic 98 
groups represents a critical step in the development of any putative biomarkers.  99 
An additional advantage of such research in Asian countries is the very low prevalence of 100 
cannabis and other drug use 27. Substance use is more frequent in patients with psychotic disorders 101 
in Western countries 28 and could be a problematic confound for ARMS research in Western 102 
populations 29,30. Substance use, and cannabis in particular, have been associated with structural 103 
changes in at-risk populations 31-34.  104 
We used both voxel-based (VBM) and surface-based (SBM) morphometry analyses to run a 105 
comprehensive and not regionally biased whole-brain investigation of baseline GMV, WMV, and 106 
cortical thickness (CT) alterations in a relatively large sample of 69 ARMS individuals with 107 
minimum antipsychotics or substance use recruited from Singapore as part of the Longitudinal 108 
Youth At-Risk Study (LYRIKS) 35. Given the good statistical power offered by our large sample 109 
size, we hypothesized that we should reproduce some of the grey and white matter volume and 110 
cortical thickness alterations in the frontal and temporal lobes as reported by previous whole-brain 111 
studies.  112 
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Methods and Materials 113 
Participants 114 
Our sample comprised 75 ARMS subjects and 40 HC between 14 and 29 years old, matched 115 
for age, gender, handedness and educational level. The participants were part of the Longitudinal 116 
Youth At-Risk Study (LYRIKS), in Singapore. ARMS subjects were recruited from programs 117 
targeted at identifying individuals at-risk for developing psychosis run by the Institute of Mental 118 
Health, and from various community mental health agencies. Details of the recruitment strategy 119 
were previously reported 36. In brief, we adopted an active approach of recruiting individuals from 120 
various psychiatric clinics and community mental health agencies, and a passive approach of self-121 
referrals from print and social media advertisements. ARMS subjects met inclusion criteria for the 122 
prodromal state of schizophrenia in accordance to the comprehensive assessment of at-risk mental 123 
states (CAARMS) 3. CAARMS assessments were performed by experienced psychometricians that 124 
were trained at ORYGEN in Melbourne. Inter-rater reliability was established and monthly 125 
supervisions were conducted throughout the study period to guarantee diagnostic validity. At-risk 126 
participants had no history of psychiatric, neurological or serious medical disorders, or mental 127 
retardation; and were not on antipsychotic medications. We excluded anyone with a current 128 
substance abuse as defined by the DSM-IV. Six AMRS subjects and 1 HC had a past history of 129 
substance use disorder (Table 1). 6 ARMS subjects and 8 HC were excluded from the original 130 
sample due to the use of a different T1-weighted structural MRI sequence (n=10) or the presence of 131 
gross structural abnormalities or movement artifacts (n=4). The demographics and clinical 132 
information of the remaining 69 ARMS and 32 HC are detailed in Table 1. Out of 69 ARMS 133 
subjects, 33 had a concomitant diagnostic of depression and/or anxiety and 37 were medicated with 134 
antidepressants, mostly selective serotonin reuptake inhibitor (SSRI, n=28), but also non-SSRI 135 
(n=7) or both SSRI and non-SSRI in association (n=2). During 28-month follow-up, 7 ARMS 136 
subjects converted to psychosis and 13 withdrew from the study, leaving a final sample of 56 137 
ARMS-NT and 7 ARMS-T at baseline.  138 
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Additional exclusion criteria for controls were: (i) history of severe head injury, (ii) personal 139 
history of psychotic disorder, (iii) and personal history of other neuropsychiatric disorder. Controls 140 
did not have any family history of neuropsychiatric disorders, except, three controls had a first-141 
degree relative with a history of depression, two had a second-degree relative with history of 142 
schizophrenia (n=1) or depression (n=1). In both the ARMS and HC groups, Primary School 143 
Leaving Examination (PSLE) scores, which are the result of a standardized multidisciplinary test of 144 
scholastic achievement, were used as a measure of educational level. Written informed consent was 145 
provided by all participants aged 21 and above or from a legally acceptable representative for 146 
participants under 21 with participant’s assent. Ethics approval for this study was provided by the 147 
National Healthcare Group’s Domain Specific Review Board. 148 
 149 
Image acquisition 150 
T1-weighted structural MRI data were obtained from a 3T Siemens Trio Tim scanner 151 
(Siemens, Erlangen, Germany) at the Center for Cognitive Neuroscience, Duke-NUS Graduate 152 
Medical School, Singapore. The principal sequence relevant to this study was a T1-weighted 3-D 153 
magnetization-prepared rapid-acquisition gradient echo (MPRAGE) sequence optimized for grey-154 
white matter contrast. It was identical to that used by the Alzheimer's Disease Neuroimaging 155 
Initiative ADNI consortium 37. Parameters were as follows: TR = 2300 ms, TE = 2.98 ms, TI = 900 156 
ms, flip angle = 9°, BW = 240 Hz / pixel, FOV = 256 ×240 mm, Matrix = 256 × 240; resulting 157 
voxel dimensions: 1.0 × 1.0 × 1.0 mm, acquisition time 5 min 03 sec. Parallel imaging was used to 158 
improve the signal-to-noise ratio instead of shortening the scan time. We obtained a single high-159 
quality image instead of averaging two or more rapidly acquired images. Images were inspected for 160 
motion artifact at the time of acquisition and scanning was repeated as necessary. Images were 161 
reviewed for any gross pathological findings. 162 
 163 
Voxel-based morphometry 164 
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Every scan was visually checked to exclude the presence of artifacts or gross anatomical 165 
abnormalities that could impact image pre-processing. Voxelwise analyses of brain GMV and 166 
WMV differences were conducted using the DARTEL (Diffeomorphic Anatomical Registration 167 
Through Exponentiated Lie Algebra) procedure 38 implemented in SPM8 168 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) running under MATLAB 2009b 169 
(http://www.mathworks.com.au/products/matlab/). Briefly, each participant’s T1-weighted 170 
anatomical scan was segmented into distinct tissue compartments (i.e. GMV and WMV) and 171 
spatially normalized via a non-linear algorithm using a unified procedure 38. A study-specific 172 
template was then generated by normalizing each participant’s segmented grey or white matter 173 
image to a common space. Native-space grey or white matter images were then spatially normalized 174 
to this template. Jacobian modulation of voxel intensities was employed to preserve grey or white 175 
matter volumes. The images were smoothed with an 8 mm full-width-half-maximum Gaussian 176 
kernel prior to statistical analysis. 177 
The General Linear Model (GLM) was used to test for group differences in volume at each 178 
voxel, as implemented in Randomise (http://fsl.fmrib.ox.ac.uk). All results were corrected for 179 
multiple comparison type I error with a non-parametric cluster-size based procedure 39,40. A voxel-180 
wise threshold was initially set to 0.001 to compromise between sensitivity to spatially extended vs. 181 
focal and intense differences. Then, a cluster-size threshold was calculated via permutation testing 182 
(10,000 permutations). We compared baseline GMV and WMV between ARMS group and HC 183 
group, while covarying for age, gender, intracranial volume (ICV), handedness and ethnicity. 184 
 185 
Surface-based morphometry 186 
The semi-automated cortical thickness measurements were performed using FreeSurfer v5.1.0 187 
(http://surfer.nmr.mgh.harvard.edu/; Martinos Imaging Centre, Charlestown MA), as described by 188 
Dale, Fishl and colleagues 41,42.  189 
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The white (i.e., gray-white matter boundary) and pial (gray-cerebrospinal fluid boundary) 190 
surfaces were visually inspected and edited, where necessary, using standard procedures 191 
(http://surfer.nmr.mgh.harvard.edu/fswiki/Edits), blind to diagnostic status. Surfaces for each 192 
participant were registered to a study specific template and smoothed using a Gaussian kernel of 25 193 
mm prior to group analysis.  194 
We used a GLM implemented in Freesurfer to estimate group differences in cortical thickness 195 
at each vertex of the cerebral surface while controlling for the effect of age, gender, handedness, 196 
and ethnicity. Right and left hemispheres were tested separately. False Discovery Rate (FDR) p < 197 
0.05 was used for multiple comparison correction.  198 
 199 
Volume-of-interests measurements 200 
We derived five volume-of-interests measurements from the Freesurfer analysis: total 201 
intracranial volume (ICV), total GMV, total WMV, hippocampal volume, and ventricular volume. 202 
ICV was calculated using a validated method described elsewhere 43. Total ventricular volume was 203 
defined as the total volume of lateral ventricles, third ventricle, fourth ventricle, and fifth ventricle. 204 
Statistical analyses were performed with the Statistical Package for the Social Sciences, 205 
version 21 (SPSS 21.0, IBM Corp. Armonk, NY, USA). Differences in cerebral volume were tested 206 
using one-way analysis of covariance (ANCOVA) with age, gender, handedness, ethnicity, and ICV 207 
as covariates.  208 
 209 
 210 
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Results 211 
Demographics and volume-of-interest differences 212 
There was no group difference in sociodemographics (age, gender, handedness, ethnicity, and 213 
educational level) or past history of substance use disorder (Table 1). No group difference in 214 
intracranial volume (ICV), total GMV, total WMV, hippocampal volume or ventricular volume 215 
between ARMS and HC was observed (Table 1). 216 
 217 
GMV and WMV differences between ARMS subjects and healthy controls 218 
We found no regional GMV or WMV differences between ARMS and HC (i.e., voxel-wise 219 
clustering-forming threshold of p<0.001 and p < 0.05 corrected at the cluster level). Lowering the 220 
initial voxel-wise cluster-forming threshold to p < 0.01 did not return significant group differences 221 
either (p < 0.05 corrected at the cluster level).  222 
At a voxel-wise threshold of p < 0.001 and k > 10 voxels (uncorrected at the cluster level), we 223 
found one cluster of increased GMV on the right precentral gyrus (k = 88 voxels, t peak = 3.64, 224 
MNI = 4, 9, 44) and a second cluster of decreased GMV on the right frontal inferior gyrus (k = 17 225 
voxels, t peak = 3.58, MNI = 46, 15, 21) in ARMS when compared to HC.  226 
 227 
Cortical thickness differences between ARMS subjects and healthy controls 228 
We found no regional cortical thickness differences between ARMS and HC at p < 0.05 (FDR 229 
corrected). At a voxel-wise cluster-forming threshold of p < 0.001 (uncorrected at the cluster level) 230 
we found one cluster of increased cortical thickness on the right frontal pole in ARMS when 231 
compared to HC (k = 230 vertices, t peak = 3.78, MNI = 21, 69, -2). 232 
 233 
Conversion to psychosis 234 
We found no significant difference between HC and ARMS-T, or between ARMS-T and 235 
ARMS-NT concerning GMV, WMV, cortical thickness or VOI analyses based on the same set of 236 
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thresholds. For the VBM analysis, lowering the initial voxel-wise cluster-forming threshold to p < 237 
0.01 (p < 0.05 corrected at the cluster level) did not return significant group differences either.  238 
 239 
Comorbid depression and anxiety disorders.  240 
To investigate structural differences that could be related to anxio-depressive disorders and 241 
that affect a large proportion of AMRS individuals, we compared GMV, WMV, CT and VOI 242 
between ARMS with a concomitant diagnostic of depression and/or anxiety (n = 33) and ARMS 243 
without (n = 36). We found no significant differences. An additional comparison of GMV, WMV, 244 
CT, and VOI between ARMS individuals with antidepressant (n = 37) and those without (n = 32) 245 
found no significant difference either.  246 
 247 
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Discussion 248 
Although there is evidence for the involvement of frontal, temporal and limbic areas in 249 
ARMS for psychosis, the sample size of previous studies is often modest and findings mainly 250 
concern ARMS samples from Western countries. In this study, we examined brain structural 251 
changes in a large sample of 69 ARMS subjects recruited in Singapore, and for which potential 252 
biases introduced by drug use, including antipsychotics and cannabis, were well controlled. 253 
Comparison of regional GMV, WMV, and CT as well as ventricular and hippocampal volumes 254 
between ARMS individuals and HC revealed no significant differences. The further analysis of the 255 
same structures between ARMS-T and ARMS-NT as well as between ARMS-T and HC did not 256 
return any positive result either.    257 
Regional reductions of GMV in ARMS subjects are the most common findings in whole-258 
brain VBM studies 15,44. Only 3 whole-brain VBM studies reported negative findings but their 259 
ARMS sample was either unusually young (12-18 years old) 20,22 or small (n=14) 26. Concerning 260 
CT, only one previous study 18 used the same preprocessing technique (Freesurfer), while three 261 
others 17,19,20 used a different algorithm: CLASP 45 or voxel-based cortical thickness 46. Their 262 
findings were divergent, reporting either extended 17 or no CT differences at the whole-brain level 263 
18-20
 in ARMS subjects when compared to HC at baseline. Our results are consistent with the 264 
absence of cross-sectional difference between ARMS subject and HC at the whole-brain level 265 
reported by the three largest studies 18,19,22. Additional comparison of hippocampal volumes 266 
between ARMS and HC showed no significant difference as well. Reduced hippocampal volume is 267 
a frequent finding from region-of-interest studies in ARMS samples 47-51 and has been shown to be 268 
statistically significant at the whole-brain level in one VBM study 4, although some inconsistences 269 
have also been reported 52,53. The higher sensitivity of manual tracing methods to detect volumetric 270 
changes in medial temporal structures could explain our inability to replicate hippocampal volume 271 
reduction often reported by manually traced region-of-interest studies in ARMS samples. However, 272 
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Freesurfer automated segmentation performance has been shown to produce volumetric data that 273 
were very close to those obtained with the “gold standard” manual tracing method 54. 274 
The sensitivity of our analyses did not improve when specifically comparing ARMS-T with 275 
HC or ARMS-NT. However, these additional group comparisons were clearly underpowered due to 276 
the small number of subject in the ARMS-T group (n = 7). A recent well powered study has also 277 
reported the absence of structural abnormalities in ARMS-T when compared to ARMS-NT at the 278 
whole brain level 19. There was lack of evidence on the structural differences between ARMS-T and 279 
ARMS-NT or HC at the baseline.  280 
The absence of relationship between clinical high-risk status (regardless of later transition or 281 
non-transition to psychosis) and brain structure might be attributed to unique characteristics of 282 
LYRIKS. Understanding the local pathways to care for the ARMS subjects is an important area of 283 
work, and efforts are currently underway. In a previous publication, we found that LYRIKS sample, 284 
was comparable to other samples from the UK or Australia concerning social and clinical profiles 285 
35
. Accordingly, clinical characteristics reported in Table 1 (i.e., CAARMS ratings, grouping and 286 
comorbidities) are also comparable to those from OASIS and PACE samples 55, although the rate of 287 
conversion to psychosis (i.e., 10% at 28-month) is probably among the lowest reported 1. However, 288 
ethnicity differences might be contributing to the negative findings as most participants in the 289 
LYRIKS sample have Asian origins. Another interesting difference could be the relative lack of 290 
drug use, including cannabis and/or antipsychotics in our sample. Half the ARMS individuals were 291 
pharmacologically treated for depression and/or anxiety and both the medication and the affective 292 
disorder could potentially impact brain structure. Last, the relatively conservative whole-brain 293 
approach could explain divergences with other region-of-interest studies. These four points are 294 
developed below. 295 
 296 
Ethnicity 297 
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It is widely recognized that the expression of psychotic symptoms varies among ethnic groups 298 
56,57
. Although these disparities seem more related to psychosocial inequalities than to ancestry 299 
differences 58, it raised the idea that ethnical differences could be instructive regarding the 300 
pathogenesis of schizophrenia 59. Accordingly, a structural MRI study reported an effect of ethnicity 301 
on gray-matter findings following a first episode of psychosis 60. These neuroimaging findings 302 
should be interpreted with caution regarding the modest sample size and the abundance of possible 303 
confounds, nevertheless, they suggest that some neuroanatomical features of psychosis could be 304 
specific to the ethnic group under investigation. In general, it is not very likely that our negative 305 
findings are attributable to the ethnical characteristics of our sample alone. Nevertheless, a different 306 
genetic background may modify the susceptibility of the brain to different etiological factors 61 and 307 
could impact the neuroanatomical correlates of the pathophysiological process.   308 
 309 
Drugs 310 
Singapore has the second lowest annual prevalence of cannabis-use worldwide (0.005 in 311 
2006) 62 and no participant in our sample reported current illicit drug use. While most neuroimaging 312 
studies in ARMS excluded subjects with current and/or past substance abuse and/or dependence 313 
regarding the DSM or the International Classification of Diseases (ICD), they possibly included 314 
cannabis users as long as they did not fulfill the criteria for abuse of dependence. Only few studies 315 
specified the proportion of cannabis users in their sample but the reported rate can be as high as 35 316 
% for current use 9,63 and up to 70% for a history of cannabis use 10. In these previous studies, the 317 
prevalence of cannabis use did not statistically differ between ARMS subjects and controls, 318 
suggesting that neuroimaging findings were not driven by cannabis use only. Nevertheless, this 319 
does not exclude the possibility that cannabis use could act as a risk-modifying factor by interacting 320 
with other risk factors like genetics and have more dramatic consequences in the group of ARMS 321 
than in healthy controls 64,65. Accordingly, three recent studies in early psychosis have shown that 322 
the amount of grey matter loss in the cingulate cortex was either positively correlated with 323 
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cannabis-use 34,66 or restricted to cannabis-users only 67. Moreover, the hippocampus is rich in 324 
endocannabinoid receptors and hippocampal volume reduction has been strongly associated with 325 
cannabis use in a recent meta-analysis 68, suggesting that the absence of hippocampal atrophy in our 326 
sample may be partly related to the relative lack of cannabis use. 327 
Antipsychotics are another potential confounding factor because they have been shown to 328 
alter GMV in schizophrenia after both continued 69 and short-term treatment 70 administration. In 329 
this study, we can exclude the potential influence of antipsychotic treatment on our results as only 3 330 
subjects received a very small dose (< 15mg week of haloperidol equivalent). However, the absence 331 
of antipsychotic use is unlikely to explain our negative findings, given the results of a recent meta-332 
analysis indicating an effect of antipsychotics on GMV in the opposite direction (i.e., antipsychotics 333 
reverse the GMV reductions associated with a greater risk of transition to psychosis) 15. 334 
 335 
Affective comorbidity 336 
Approximately half of ARMS individuals in our sample had a comorbid depressive and/or 337 
anxious disorder, a proportion that is comparable with other ARMS samples 55. Disentangling 338 
emerging psychosis with concomitant mood disturbances from depression or anxiety with 339 
attenuated psychotic symptoms is challenging from both a clinical and neuroanatomical point of 340 
view. Similarly to psychosis, affective disorders may also show neuroanatomical features within 341 
medial prefrontal and medial temporal structures 71 and this could represent an important source of 342 
confound for neurostructural findings in ARMS. Accordingly, a recent study showed that comorbid 343 
depression and anxiety may contribute to GMV reduction in the anterior cingulate cortex in ARMS 344 
72
. In our sample, we did not find any effect of comorbid depression and/or anxiety or 345 
antidepressant treatment on regional GMV, WMV, CT or VOI. However, we cannot exclude that 346 
antidepressant treatment may have interfered with the natural course of ARMS individuals 73,74.  347 
 348 
Whole-brain analysis  349 
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We made the initial choice of a whole-brain analysis because it is a common and well 350 
accepted statistical approach for both VBM and SBM analyses. Moreover, in the context of an 351 
excess of significance in the neuroimaging literature 75,76, the whole-brain approach limits the risk 352 
of publication bias toward positive findings that is thought to be partially responsible for the lack of 353 
reliable biomarkers in psychiatry despite intense research in neuroimaging 77. Indeed, region-of-354 
interest studies are directed towards regions that can be easily anatomically delimited or regions of 355 
theoretical importance, which intrinsically depend on results from previous studies, thereby 356 
inflating the risk of confirmation bias. We completed the initial whole-brain approach with the 357 
individual analysis of two VOIs (i.e. ventricles and hippocampus) that are commonly implicated 358 
among structural findings in psychosis but are the best assessed individually, using volumetric 359 
information from the subcortical segmentation in Freesurfer. Instead of running additional region-360 
of-interest analyses in the hypothesized fronto-temporal and limbic regions, we examined the group 361 
difference using p < 0.001 uncorrected, at the voxel or the vertex level for both the VBM and SBM 362 
analyses respectively. In the context of the literature, neither the direction of the trend (i.e., 363 
increased GMV or CT), nor the location of the clusters (i.e. precentral gyrus, frontal pole) advocate 364 
in favor of true differences between ARMS and HC. For inclusion of these data in a meta-analysis, 365 
GMV, WMV or CT for a specific region are available on request to the corresponding author (J.Z). 366 
Our results might also be limited by the cross-sectional design of the study. Cannon and 367 
colleagues have recently reported greater GM loss over time in several frontal areas of ARMS-T 368 
when compared to ARMS-NT or HC, although they observed no CT differences between all 3 369 
groups when compared cross-sectionally at baseline 18. 370 
Last, our analysis was limited to anatomical changes in gray and white matter segments. Two 371 
functional MRI studies in the same ARMS sample have previously reported alterations in task-372 
based activations 78 as well as abnormalities in functional-connectivity at rest 79 when compared to 373 
HC. This suggests that, in our sample, (1) there might be very little structural change in ARMS or 374 
(2) VBM and SBM analyses may not be sensitive to detect subtle structural differences. Functional 375 
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or diffusion MRI studies might reveal more insights on the pathophysiology changes in youths at 376 
high clinical risk for psychosis. 377 
 378 
Conclusion 379 
Taken together, this comprehensive cross-sectional analysis of regional volumes and cortical 380 
thickness was conducted in a relatively large sample of ARMS subjects, mainly free of possibly 381 
important confounds including antipsychotic medication and substance abuse. Only few whole 382 
brain studies have examined brain structural changes in an ARMS sample of comparable size, 383 
particularly in Asian populations 80. We found no evidence of regional GMV, WMV or CT 384 
differences between ARMS and HC, ARMS-T and HC or ARMS-T and ARMS-NT at baseline. 385 
The small number of ARMS transitioning to psychosis and the absence of longitudinal analysis of 386 
brain changes over-time are clear limitations, especially in light of recent findings suggesting 387 
progressive structural changes in ARMS despite the absence of baseline differences with HC 18. 388 
Nevertheless, our negative findings suggest that there may be no dramatic alterations of regional 389 
brain volumes or cortical thickness in ARMS when the incidence of possible confounds is limited.  390 
  391 
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Figure legends 609 
Table 1. Demographic, clinical and anatomical characteristics of participants 610 
APS, attenuated psychotic symptoms; BAI, Beck anxiety inventory; BLIPS, brief limited 611 
intermittent psychotic symptoms; CAARMS, comprehensive assessment of at-risk mental 612 
states; CDSS, Calgary depression scale for schizophrenia; GRD, genetic risk and 613 
deterioration syndrome; GM, grey matter; ICV, intracranial volume; PSLE, primary school 614 
leaving examination; SBM, surface-based morphometry; SUD, substance use disorder; 615 
VBM, voxel-based morphometry; WM, white matter; Percentages were rounded to the 616 
nearest integer. All ARMS and control subjects belong to the three major ethnicities in 617 
Singapore (Chinese, Malay and Indian), except two ARMS (Javanese and Eurasian) and two 618 
controls (Javanese and Israeli).  619 
 620 
 621 
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